ATE361082T1 - Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung - Google Patents

Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung

Info

Publication number
ATE361082T1
ATE361082T1 AT00905836T AT00905836T ATE361082T1 AT E361082 T1 ATE361082 T1 AT E361082T1 AT 00905836 T AT00905836 T AT 00905836T AT 00905836 T AT00905836 T AT 00905836T AT E361082 T1 ATE361082 T1 AT E361082T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
complex carbohydrates
methods
pharmaceutical compositions
application
Prior art date
Application number
AT00905836T
Other languages
English (en)
Inventor
Harold G Brown
Carol A Cooper
Kristina J Hennessy
Karen K Brown
Original Assignee
Dermal Res Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermal Res Lab Inc filed Critical Dermal Res Lab Inc
Application granted granted Critical
Publication of ATE361082T1 publication Critical patent/ATE361082T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00905836T 1999-02-01 2000-02-01 Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung ATE361082T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11798899P 1999-02-01 1999-02-01
US12774999P 1999-04-05 1999-04-05
US13709899P 1999-06-02 1999-06-02
US14230699P 1999-07-03 1999-07-03
US16632699P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
ATE361082T1 true ATE361082T1 (de) 2007-05-15

Family

ID=27537501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905836T ATE361082T1 (de) 1999-02-01 2000-02-01 Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung

Country Status (7)

Country Link
US (3) US8003782B1 (de)
EP (1) EP1165097B1 (de)
AT (1) ATE361082T1 (de)
AU (1) AU2745700A (de)
CA (1) CA2361268C (de)
DE (1) DE60034667T2 (de)
WO (1) WO2000044367A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
AU2001264817A1 (en) * 2000-05-23 2001-12-17 Exhale Therapeutics, Inc. Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
US7635489B2 (en) 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
DE102004002001A1 (de) 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
DE102005004643B4 (de) * 2005-01-28 2010-04-08 Innovent E.V. Technologieentwicklung Antivirale Kombinationen sowie ihre Verwendung
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
FR2921260B1 (fr) * 2007-09-25 2012-08-24 Lesaffre & Cie Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
EA018333B1 (ru) * 2008-05-13 2013-07-30 Афарм С.Р.Л. Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
US9241953B2 (en) 2008-05-13 2016-01-26 Apharm S.R.L. Glycosaminoglycan oral use and compositions
US9918489B2 (en) 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
JP5437692B2 (ja) * 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
US20110123639A1 (en) * 2009-11-26 2011-05-26 Chan Agnes Sui-Yin Compound for improving brain functioning and/or treatment of brain disorders
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
WO2012170504A2 (en) 2011-06-06 2012-12-13 The Cleveland Clinic Foundation Treatment of extracellular matrix to reduce inflammation
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
US9662358B2 (en) * 2011-10-18 2017-05-30 Nestec S.A. Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
US9480747B2 (en) 2012-01-24 2016-11-01 Bvw Holding Ag Class of anti-adhesion hydrogels with healing aspects
CA2887852A1 (en) 2012-10-02 2014-04-10 Aloe Bioscience, Llc. Polysaccharide extract of aloe vera and use thereof for treating decubitus ulcers
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
US10668190B2 (en) 2016-05-03 2020-06-02 Bvw Holding Ag Multiphase gel
US20200038308A1 (en) * 2018-08-06 2020-02-06 Kate Somerville Skincare, LLC Wrinkle reducing compositions and methods
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
BR112023022331A2 (pt) 2021-05-12 2023-12-26 Nexeos Diagnostics Inc Métodos de fabricação de um composto de heparina de alto peso molecular
EP4590128A2 (de) 2022-09-22 2025-07-30 Bluetree Technologies Ltd Verfahren und systeme zur herstellung von getränken mit niedrigem zuckergehalt

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895107A (en) 1970-04-15 1975-07-15 Morrison L M CSA and CSC in man and mammals to inhibit atherosclerosis and the recurrence of cardiovascular incidents in atherosclerotic mammals
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4148887A (en) 1977-06-13 1979-04-10 The Procter & Gamble Company Dermatological compositions
US4248861A (en) 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
US4353896A (en) 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4440777A (en) 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US5308838A (en) 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US4917890A (en) 1985-06-28 1990-04-17 Carrington Laboratories, Inc. Processes for preparation of aloe products, products produced thereby and compositions thereof
US4474763A (en) 1982-07-07 1984-10-02 Lubowe Irwin I Skin preparation
US4463016A (en) 1982-09-22 1984-07-31 Nel's Laboratory, Inc. Method for the treatment of razor bumps
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
JPS59163307A (ja) * 1983-03-08 1984-09-14 Kazuo Mitomo 口臭の消臭剤
DE3323389A1 (de) 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
US4521411A (en) 1983-11-04 1985-06-04 Theodora Koloff Analgesic composition
NO161573C (no) 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4564521A (en) 1984-03-21 1986-01-14 James Altadonna Medication for pain relief in joints of humans
US4585656A (en) * 1984-08-20 1986-04-29 Rosenthal Harold R Treatment of herpes
US4933183A (en) * 1984-10-05 1990-06-12 Warner-Lambert Company Novel drug delivery system for mineral supplements
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4707354A (en) 1985-06-17 1987-11-17 Alpen Tau, Inc. Mature skin treatment and protectant compositions and methods of using same
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS6277308A (ja) 1985-09-30 1987-04-09 Kobayashi Kooc:Kk 化粧料
US4708873A (en) 1986-01-29 1987-11-24 Schulte Thomas L Method of chemically debriding uncerated necrotic tissue
US4808576A (en) 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
EP0254845A3 (de) 1986-06-10 1989-04-19 Lescarden Inc. Immun-Stimulation mit Chondroitin-sulfat
JPS638309A (ja) * 1986-06-26 1988-01-14 Ichimaru Pharcos Co Ltd 芳香精油成分の包接物を含有する浴用剤又は使用時溶解化粧料
US4847078A (en) 1987-01-14 1989-07-11 Arseco, Inc. Storage stable topical composition having moisture control agent
US5009890A (en) 1987-08-10 1991-04-23 Trilling Medical Technologies, Inc. Burn treatment product
US5082656A (en) 1987-04-30 1992-01-21 Abbott Laboratories Topical antibacterial compositions containing penetration enchancers
US4797402A (en) 1987-06-02 1989-01-10 Dorsey Kenneth E Cooling anti-itch skin preparations
US4883664A (en) 1987-06-29 1989-11-28 Mary Sharkey Medicinal salve
US4800197A (en) 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US4900550A (en) 1987-08-19 1990-02-13 Amy Allene Cosmetiques, Inc. Skin care cosmetic regime
JPH01186824A (ja) 1988-01-19 1989-07-26 Horiuchiitarou Shoten:Kk 外皮投与用組成物及び経皮吸収を促進する方法
US5096709A (en) 1988-05-09 1992-03-17 Melaleuca, Inc. Muscle relaxant and analgesic containing oil of Melaleuca, spp.
WO1990000058A1 (de) 1988-06-27 1990-01-11 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie
DE3836971C1 (de) 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De
US5028429A (en) 1989-01-17 1991-07-02 Gochenouer Charles J Leg blister
ATE107517T1 (de) 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5073366A (en) 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
US4973473A (en) 1989-06-23 1990-11-27 Revlon, Inc. Skin care preparation
US5013726A (en) 1989-09-12 1991-05-07 Ivy Jeffery W External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion
IT1240316B (it) 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
JP2769584B2 (ja) 1990-06-04 1998-06-25 参天製薬株式会社 局所投与用抗アレルギー剤
AU630561B2 (en) 1990-06-12 1992-10-29 Cathy Palou A therapeutic preparation containing myrrh for treating skin disorders
US5331012A (en) 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
IT1245761B (it) 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
US5106622A (en) 1991-03-12 1992-04-21 Karen Sherwood Repellent composition containing natural oils of citronella, cedar and wintergreen and use thereof
FR2674749B1 (fr) 1991-04-05 1995-06-02 Thorel Jean Noel Bases cosmetiques et dermatologiques a base d'huiles essentielles, et procedes et appareillages correspondants.
CA2108569A1 (en) 1991-04-17 1992-10-18 H. Edward Conrad Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1251182B (it) 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
US5215759A (en) 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
EP0571597A4 (en) 1991-11-15 1994-06-01 Arthro Res & Dev Corp Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
US5266318A (en) * 1991-12-09 1993-11-30 Royale Renaissance, Inc. Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed
CA2130762C (en) 1994-08-24 1999-07-06 Eva Anne Turley Treatment of disease and conditions associated with macrophage infiltration
US5223257A (en) 1992-03-11 1993-06-29 Vasu Arora Topical composition for relieving aches and pains
JPH06107550A (ja) 1992-09-29 1994-04-19 Yutaka Kurachi 経口抗炎症剤
US5460821A (en) 1993-06-23 1995-10-24 Masiz; John J. Molecular transdermal transport system
US5559103A (en) * 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
EP0749314A4 (de) 1994-03-02 2002-09-18 Neose Technologies Inc Verfahren zur behandlung und inhibierung der magen- und zwölffingerdarmgeschwüren
US5604200A (en) * 1994-05-02 1997-02-18 Taylor-Mccord; Darlene Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
FR2719772B1 (fr) 1994-05-11 1996-08-02 Goemar Lab Sa Composition cosmétique ou pharmaceutique, notamment dermatologique contenant de la laminarine ou des oligosaccharides dérivés de laminarine.
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5639469A (en) 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
IT1270095B (it) 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
DE69532293T2 (de) 1994-12-01 2004-10-21 Seikagaku Kogyo Co Ltd Keratansulfatoligosaccharid-fraktion und sie enthaltendes medikament
ES2180757T3 (es) 1995-04-11 2003-02-16 Neose Technologies Inc Sintesis enzimatica mejorada de oligosacaridos.
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
DE19520575A1 (de) * 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
CA2156013A1 (en) 1995-08-14 1997-02-15 Samuel Simon Asculai Modulation of cellular activity
US6537977B1 (en) 1995-09-19 2003-03-25 Seikagaku Corporation Anti-inflammatory agent
DE19547105A1 (de) 1995-12-16 1997-06-19 Schmidt Ernst Guenther Dipl Ph Arzneimittel aus Hirudin, Heparin, deren Abkömmlinge oder Heparioniden
EP0873128B1 (de) 1996-01-11 2004-11-17 Jagotec Ag Orale verabreichung wirksamer mengen von hyaluronsäure
US6875753B1 (en) 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
DK0914133T3 (da) 1996-03-14 2003-11-17 Univ Alberta Anvendelse af hyaluronan (HA) til cellemobilisering
JPH09262057A (ja) * 1996-03-28 1997-10-07 Kaken:Kk 口臭除去食物
CA2175282A1 (en) 1996-04-29 1997-10-30 Rudolf Edgar Falk Use of forms of hyaluronic acid (ha) for the treatment of cancer
US5654412A (en) 1996-05-29 1997-08-05 Glycomed Incorporated Processes for the synthesis of sialyl Lewisx compounds
CA2260854A1 (en) 1996-08-08 1998-02-19 Novartis Ag Modified oligosaccharides
AU4700497A (en) 1996-08-26 1998-03-19 Novartis Ag Organic compounds
US5929050A (en) 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
US6391864B1 (en) 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6924273B2 (en) 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
US7635489B2 (en) 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
US6607745B2 (en) 2001-05-18 2003-08-19 Harry Leneau Ingestion of hyaluronic acid for improved joint function and health

Also Published As

Publication number Publication date
EP1165097A2 (de) 2002-01-02
US20110269710A1 (en) 2011-11-03
DE60034667T2 (de) 2008-03-13
CA2361268A1 (en) 2000-08-03
US8003782B1 (en) 2011-08-23
AU2745700A (en) 2000-08-18
DE60034667D1 (de) 2007-06-14
WO2000044367A3 (en) 2000-12-21
US9220290B2 (en) 2015-12-29
EP1165097B1 (de) 2007-05-02
CA2361268C (en) 2014-06-10
US20130296266A1 (en) 2013-11-07
WO2000044367A2 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
DE60034667D1 (de) Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung
WO2000027381A3 (en) Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
DE60134855D1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
US6911196B2 (en) Topical medicament for treating nappy rash
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
ATE526956T1 (de) Viruzide zusammensetzungen
CA2274074A1 (en) Novel compounds with analgesic effect
ZA872120B (en) Pharmaceutical composition
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
ATE410158T1 (de) Fulvinsäure und deren verwendung in der behandlung von viralen infektionen
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
AU2002227052A1 (en) Treatments for neurogenetic disorders, impulse control disorders, and wound healing
EP0417105A4 (en) Topically applied gold organic complex
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
WO2003057172A3 (en) Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
BRPI0417116A (pt) usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
CN112867540A (zh) 用于组织和骨再生的臭氧化的植物治疗组合物
NZ336600A (en) Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation
ATE83657T1 (de) Pharmazeutische zusammensetzung.
CA2524921A1 (en) Method and composition for treating burned skin
FI962506A0 (fi) Psoriasiksen hoito
DE60012575D1 (de) Nsaid enthaltendes wasserfreies gel zur topischen anwendung in der mundhöhle
EP3348307A1 (de) Zusammensetzung mit carnitin, natriumcholat, natriumacetat und gegebenenfalls silber zur verwendung in der behandlung von psoriasis, vitiligo und rosazea
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165097

Country of ref document: EP